Styrenix Perfor. Q2 FY27 Earnings Call — Analysis (NSE: STYRENIX)

Styrenix reported steady standalone Q2FY27 revenue growth of 26.5% YoY to ₹781 Cr, while Phase 1 ABS expansion remains on track for commissioning by end-FY27 and Thailand operations face an extended two-year turnaround timeline.

5 Nov 2026 · Analysis by Alpha Inflection

Result quality: stable — Steady quarter. Management sentiment: optimistic.

The take

Q2FY27 Standalone Revenue ₹781 Cr ( +26.5% YoY ) . New guidance — H2 FY27 abs sales volume h2 fy27 in line with Q2 FY27 volumes . New story: Margin normalisation anchoring .

Results

Standalone revenue rose 26.5% YoY to ₹781 Cr with EBITDA of ₹84.5 Cr (+3.3% YoY, margin 10.8%) and PAT of ₹51.2 Cr (+0.8% YoY); consolidated revenue stood at ₹997 Cr with EBITDA margin of 7.6%.

Financial highlights

Guidance

Phase 1 ABS expansion across Nandesari, Katol, and Moxi will come on stream towards the end of FY27, with Thailand restructuring expected to take another 1.5 to 2 years to achieve structural profitability.

What management committed to

• We believe the second half volumes of ABS will be in line with what we've already seen in the second quarter [of FY27] and the business [ABS] will be back to normal. — in line with Q2 FY27 volumes, H2 FY27
• We are going ahead with that expansion on Phase 2 [of ABS] as well. And this would happen as per the time line we have originally planned. — no change to previously planned timeline, Not specified (beyond Phase 1 timeline)
• We do believe with [Thailand] cost reduction measures... within a year or two, say, two years, we are able to completely get [cost structure] in control... even at current volumes, we believe that [Thailand] would be a structurally profitable business. — structurally profitable, FY29

Key themes

Capacity expansion and Thailand operational turnaround

How the narrative shifted

• Geopolitical disruption and raw-material volatility: Geopolitical developments continue to cause extreme crude and styrene monomer price fluctuations, and the resulting volatility remains the dominant external constraint on strategic planning.
• Non-OEM demand contraction vs. resilient OEM: Management recasts non-OEM weakness as an active strategic choice to avoid speculation rather than a demand signal.
• Margin normalisation anchoring: The normalisation thesis is now confirmed by reported Q2 results rather than merely guided as a future expectation.
• ABS brownfield expansion execution: Phase 1 remains on track for FY27 completion, with month-level details now provided for commissioning sequence and capacity utilisation post-commissioning.
• Thailand turnaround via market development: Management transitions from framing Thailand as a developing growth story to actively warning against near-term improvement and positioning the next two years as a stable baseline.
• Capital allocation discipline: No mention of shareholder returns philosophy in this call, as focus is fully on expansion capex and operational challenges.
• Competitive and import dynamics: Import data remains unavailable, but management reports no material change in competitive intensity despite a new domestic ABS player entering and general pricing pressures.
• Speculative procurement avoidance strategy: Management explicitly and repeatedly articulates a policy of refusing to buy raw material on speculation for non-OEM segments, accepting volume loss to avoid inventory losses from price volatility.
• Product mix enrichment and specialty-grade push: Management highlights launches of ASALAC (ASA) and STYROLOY (blends) as new revenue streams and positions refrigeration-liner ABS as a high-value niche with import-substitution potential.

Operational commentary

• Phase 1 ABS expansion synchronizing three facilities (Nandesari rubber, Katol SAN, and Moxi compounding) is scheduled to be commissioned in Q4FY27.
• Introducing proprietary Thailand technology to manufacture refrigeration liner ABS grades in India, targeting 30,000–40,000 tons of addressable import volume where domestic competitors currently lack approved grades.
• HIPS operating at near-full capacity utilization with 70–80% tied to formula-based OEM contracts; management intentionally restrained GPPS volumes in Q2 to avoid speculative spot raw material exposure.
• Commercialized adjacent specialty product lines including ASALAC (weatherable ASA for automotive/EV/solar) and STYROLOY (polycarbonate/nylon ABS blends).
• Thailand turnaround requires multiple 1–1.5 year manufacturing projects focused on rubber efficiency and cost structure realignment before delivering structural profitability.

Analyst Q&A

• Q. What is the expected turnaround trajectory and volume trigger for the Thailand business over the next two years?

  Thailand's financial performance is expected to remain consistent with last year for the next 1.5–2 years while manufacturing realignment and rubber efficiency projects are executed, after which structural profitability will improve.

• Q. Will the new ABS capacity take time to ramp up, and what utilization levels are targeted for year one (FY28)?

  Declined to give formal numerical volume guidance, but noted historical capability to quickly scale ABS volumes from 60 KT to 110 KT and expressed confidence in ramping up large portions of new capacity quickly.

• Q. Are there distinct grades like refrigeration liner ABS where Styrenix faces no domestic competition?

  Confirmed that no local Indian manufacturer currently has approved refrigeration liner ABS grades; Styrenix will use Thailand technology in the new capacity to substitute the 30–40 KT import market.

View source

Research and educational content only. Not investment advice.